STOCK TITAN

[Form 4] NEOGEN CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Ashima Gupta, a director of Neogen Corporation (NEOG), reported the vesting and settlement of 2,071 restricted stock units (RSUs) into 2,071 shares of common stock on 10/07/2025. The reported per‑share value recorded on the form is $5.63, and the reporting form shows 23,988 shares beneficially owned by the reporting person following this transaction.

The filing is a routine Section 16 disclosure showing compensation‑related equity vesting rather than an open‑market buy or sell. The form was signed by an attorney‑in‑fact on 10/09/2025.

Ashima Gupta, una direttrice di Neogen Corporation (NEOG), ha riferito l'acquisizione e la regolamentazione di 2.071 unità azionarie restritte (RSU) in 2.071 azioni ordinarie il 10/07/2025. Il valore per azione riportato nel modulo è $5,63, e il modulo di segnalazione mostra 23.988 azioni di proprietà beneficiaria della persona che segnala a seguito di questa operazione.

La presentazione è una divulgazione routinaria della Sezione 16 che mostra l'acquisizione legata al compenso piuttosto che un acquisto o vendita sul mercato aperto. Il modulo é stato firmato da un procuratore in fatto il 10/09/2025.

Ashima Gupta, directora de Neogen Corporation (NEOG), informó la consolidación y liquidación de 2.071 unidades de acciones restringidas (RSU) en 2.071 acciones común en 10/07/2025. El valor por acción registrado en el formulario es $5.63, y el formulario de informe muestra 23.988 acciónes posesdas por la persona que reporta tras esta operación.

La presentación es una divulgación rutinaria de la Sección 16 que muestra la consolidación vinculada a la compensación, en lugar de una compra o venta en el mercado abierto. El formulario fue firmado por un apoderado en 10/09/2025.

Ashima GuptaNeogen Corporation (NEOG)의 이사로서 제한 주식 단위(RSU) 2,071개보통주 2,071주로 귀속 및 정산했다고 10/07/2025에 보고했습니다. 양식에 기재된 주당 가치는 $5.63이며, 보고자에 의해 이 거래 이후 23,988주의 유익하게 소유가 보고됩니다.

해당 파일은 보상 관련 주식의 귀속을 나타내는 섹션 16의 일상적 공시이며 시장에서의 매매와는 무관합니다. 양식은 10/09/2025에 대리인이 서명했습니다.

Ashima Gupta, directrice de Neogen Corporation (NEOG), a rapporté l'acquisition et le règlement de 2 071 unités d'actions restreintes (RSU) en 2 071 actions ordinaires le 10/07/2025. La valeur par action indiquée sur le formulaire est $5,63, et le formulaire de rapport montre 23 988 actions possédées par la personne qui signale à la suite de cette transaction.

Le dépôt est une divulgation routinière de la Section 16 montrant la vesting liée à la compensation plutôt qu'un achat ou une vente sur le marché libre. Le formulaire a été signé par un mandataire le 10/09/2025.

Ashima Gupta, Direktorin der Neogen Corporation (NEOG), meldete die Vesting und Abrechnung von 2.071 Restricted Stock Units (RSUs) in 2.071 Stammaktien am 10/07/2025. Der gemeldete Wert pro Aktie, der im Formular vermerkt ist, beträgt $5.63, und das Meldeformular zeigt 23.988 Aktien im direkten Eigentum der meldenden Person nach dieser Transaktion.

Die Einreichung ist eine routinemäße Offenlegung gemäße Abschnitt 16, die die vergütungsbezogenen Aktienbestand der Vesting zeigt, statt eines offenen Markt-Kaufs oder -Verkaufs. Das Formular wurde von einem Bevollmächtigten am 10/09/2025 unterschrieben.

Ashima Gupta، مديرة في Neogen Corporation (NEOG)، أبلغت عن vesting وتسوية 2,071 وحدة أسهم مقيدة (RSUs) إلى 2,071 سهماً من الأسهم العادية في 10/07/2025. القيمة لكل سهم المذكورة في النموذج هي $5.63، ويظهر نموذج التقرير 23,988 سهماً مملوكة بشكل مفيد من قبل الشخص المبلغ عنه عقب هذه الصفقة.

هذا الإيداع عبارة عن إفصاح روتيني للقسم 16 يعرض vesting المرتبط بالتعويض بدلاً من شراء أو بيع في السوق المفتوح. تم توقيع النموذج بواسطة وكيل نيابة في 10/09/2025.

Ashima GuptaNeogen Corporation (NEOG)的董事,报告了将 2,071 个受限股票单位(RSU)归属并结算为 2,071 股普通股,时间为 10/07/2025。表格上登记的每股价值为 $5.63,报告表在该交易后显示 23,988 股受报告人受益所有。

该披露是例行的第16条披露,显示与薪酬相关的股权归属,而非公开市场买卖。表格由一名代理人在 10/09/2025 签署。

Positive
  • RSUs vested and converted into 2,071 shares, aligning compensation with equity ownership
  • Insider retains 23,988 shares after settlement, showing ongoing director ownership
Negative
  • None.

Insights

Routine director RSU vesting converted to shares; limited market impact.

The transaction reflects 2,071 RSUs vesting and being settled for the same number of common shares on 10/07/2025, recorded at $5.63 per share. This is a standard equity‑compensation event that increases the director's direct share count to 23,988 shares.

The principal dependency is compensation policy and vesting schedule; there is no indication of an open‑market sale or purchase in this filing. Investors might note the change in outstanding insider holdings for short‑term ownership tracking over the next few reporting cycles.

Ashima Gupta, una direttrice di Neogen Corporation (NEOG), ha riferito l'acquisizione e la regolamentazione di 2.071 unità azionarie restritte (RSU) in 2.071 azioni ordinarie il 10/07/2025. Il valore per azione riportato nel modulo è $5,63, e il modulo di segnalazione mostra 23.988 azioni di proprietà beneficiaria della persona che segnala a seguito di questa operazione.

La presentazione è una divulgazione routinaria della Sezione 16 che mostra l'acquisizione legata al compenso piuttosto che un acquisto o vendita sul mercato aperto. Il modulo é stato firmato da un procuratore in fatto il 10/09/2025.

Ashima Gupta, directora de Neogen Corporation (NEOG), informó la consolidación y liquidación de 2.071 unidades de acciones restringidas (RSU) en 2.071 acciones común en 10/07/2025. El valor por acción registrado en el formulario es $5.63, y el formulario de informe muestra 23.988 acciónes posesdas por la persona que reporta tras esta operación.

La presentación es una divulgación rutinaria de la Sección 16 que muestra la consolidación vinculada a la compensación, en lugar de una compra o venta en el mercado abierto. El formulario fue firmado por un apoderado en 10/09/2025.

Ashima GuptaNeogen Corporation (NEOG)의 이사로서 제한 주식 단위(RSU) 2,071개보통주 2,071주로 귀속 및 정산했다고 10/07/2025에 보고했습니다. 양식에 기재된 주당 가치는 $5.63이며, 보고자에 의해 이 거래 이후 23,988주의 유익하게 소유가 보고됩니다.

해당 파일은 보상 관련 주식의 귀속을 나타내는 섹션 16의 일상적 공시이며 시장에서의 매매와는 무관합니다. 양식은 10/09/2025에 대리인이 서명했습니다.

Ashima Gupta, directrice de Neogen Corporation (NEOG), a rapporté l'acquisition et le règlement de 2 071 unités d'actions restreintes (RSU) en 2 071 actions ordinaires le 10/07/2025. La valeur par action indiquée sur le formulaire est $5,63, et le formulaire de rapport montre 23 988 actions possédées par la personne qui signale à la suite de cette transaction.

Le dépôt est une divulgation routinière de la Section 16 montrant la vesting liée à la compensation plutôt qu'un achat ou une vente sur le marché libre. Le formulaire a été signé par un mandataire le 10/09/2025.

Ashima Gupta, Direktorin der Neogen Corporation (NEOG), meldete die Vesting und Abrechnung von 2.071 Restricted Stock Units (RSUs) in 2.071 Stammaktien am 10/07/2025. Der gemeldete Wert pro Aktie, der im Formular vermerkt ist, beträgt $5.63, und das Meldeformular zeigt 23.988 Aktien im direkten Eigentum der meldenden Person nach dieser Transaktion.

Die Einreichung ist eine routinemäße Offenlegung gemäße Abschnitt 16, die die vergütungsbezogenen Aktienbestand der Vesting zeigt, statt eines offenen Markt-Kaufs oder -Verkaufs. Das Formular wurde von einem Bevollmächtigten am 10/09/2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gupta Aashima

(Last) (First) (Middle)
C/O NEOGEN CORPORATION
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/07/2025 M 2,071 A $5.63 23,988 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.63 10/07/2025 M 2,071 10/07/2025 10/07/2025 Common Stock 2,071 $5.63 0 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NEOG director Ashima Gupta report on Form 4?

The report shows 2,071 RSUs vested and were settled for 2,071 shares of common stock on 10/07/2025 at a recorded value of $5.63 per share.

Did the Form 4 report an open‑market purchase or sale by the director?

No. The filing records an RSU vesting and settlement (transaction code M), not an open‑market buy or sell.

How many shares does the reporting person own after the transaction?

The reporting person beneficially owns 23,988 shares following the reported settlement.

When was the Form 4 signed and filed?

The form shows the transaction date as 10/07/2025 and the signature (by attorney‑in‑fact) dated 10/09/2025.

What does transaction code 'M' mean on this Form 4?

Transaction code M indicates a transaction resulting from the exercise or conversion of derivative securities or the settlement of restricted stock units; here it denotes RSU vesting and settlement.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.47B
215.23M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING